United Kingdom In Vitro Diagnostics Market Insight
Published: 27 May 2026 | Report Format: Electronic (PDF)
The UK In vitro diagnostics market size is rapidly expanding, at a 3.65% CAGR, and the chronic diseases, early detection demand, and advanced molecular diagnostics adoption.
UK In Vitro Diagnostics Market Insights Forecasts to 2035
- The UK In Vitro Diagnostics Market Size Was Estimated at USD 6.721 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 3.65% from 2025 to 2035
- The UK In Vitro Diagnostics Market Size is Expected to Reach USD 9.618 Million by 2035
Notable Insights for UK In Vitro Diagnostics Market
- Molecular diagnostics account for 32% share of the United Kingdom in vitro diagnostics market, spurred by rising need for genetic tests, backed by £4Billion investments in precision medicine, infectious disease screening, and advanced genomics health care technology.
- Clinical chemistry accounts for 27% share of the United Kingdom in vitro diagnostics market, boosted by increasing burden of chronic diseases, backed by £3.5Billion investments in healthcare technology for diabetes, cardiovascular, and metabolic disorders.
- The United Kingdom NHS invests over £190Billion per year on health care, propelling the growth of the IVD market via £5Billion investments in diagnostic technologies, laboratory upgrades, digital pathology, and precision medicine technology
Download the eBook (ToC)
- Increased adoption of cancer diagnostics is taking place within the United Kingdom IVD market, fueled by growing demand for precision medicine, backed by £6Billion investments in biomarker technologies, cancer screening, and precision oncology.
Why Buy This Report
• Get comprehensive knowledge about the United Kingdom In-Vitro Diagnostics market with coverage for molecular diagnostics, clinical chemistry, immunoassays, point-of-care diagnostics, and personalized medicine diagnostic tests.
• Know about how AI-based diagnostics, genetic testing, biomarkers, automation, and digital pathology are revolutionizing the field of disease detection and healthcare management in the United Kingdom.
• Discover investment areas like molecular diagnostics tests, oncological diagnostics, laboratory automation, infectious disease detection, and advanced personalized medicine diagnostics in the UK.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the UK in vitro diagnostics market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom In Vitro Diagnostics Market
-
- Roche
- Abbott
- Siemens Healthineers
- Thermo Fisher Scientific
- Danaher
- bioMérieux
- Qiagen
- Becton Dickinson
- Others
Recent Developments:
- In January 2026, the United Kingdom strengthened healthcare digitalization and precision medicine initiatives, supported by £8Billion NHS innovation investments, accelerating molecular diagnostics, genomic testing, AI-driven pathology, laboratory automation, and advanced IVD technology adoption nationwide
- In March 2026, Roche strengthened AI-powered molecular diagnostics in the United Kingdom IVD market. Backed by £6Billion healthcare technology investments, innovations advance oncology testing, infectious disease screening, laboratory automation, and precision medicine adoption nationwide.
Market Segmentation:
United Kingdom In Vitro Diagnostics Market, By Product Type
- Reagents & Kits
- Instruments
- Software & Services
- Others
United Kingdom In Vitro Diagnostics Market, By Technology
- Molecular Diagnostics
- Clinical Chemistry
- Immunoassays
- Hematology
- Microbiology
- Others
United Kingdom In Vitro Diagnostics Market, By Application
- Infectious Diseases
- Oncology
- Cardiology
- Diabetes Testing
- Genetic Testing
- Others
United Kingdom In Vitro Diagnostics Market, By End User
- Hospitals
- Diagnostic Laboratories
- Academic & Research Institutes
- Point-of-Care Facilities
- Others
Expert Views:
The UK in vitro diagnostics market is expected to grow strongly in the coming years owing to an increase in chronic diseases, growing need for precision medicine, and greater adoption of healthcare digitalization programs by industry leaders. In addition, according to industry analysts, molecular diagnostics, laboratory automation with artificial intelligence, genomic testing, point-of-care diagnostics, and personalized healthcare would continue to drive growth of the market in the coming years.
Author: Govind and Krishna By Spherical Insights and Consulting